Andrew M. Wood, MS Voyager Therapeutics

Andrew Wood is a chemical engineer with over 10 years of biotechnology industry experience, focused on bioprocess development, clinical and commercial manufacturing support, and process validation. Andrew joined Voyager Therapeutics in 2018 as the Lead of Downstream Process Development. Andrew most recently was a Senior Manager at Axcella Health, where he was responsible for the purification, formulation, manufacturing, and supply chain of APIs and proteins from various bacterial expression systems.  Prior to Axcella, Andrew worked at Sanofi Genzyme as part of the Manufacturing Sciences and Technology (MSAT) group and Pfizer as part of the Purification Process Development group, both of which focused on protein biologics.  Andrew holds a BS in Chemical & Biological Engineering and a MS in Biotechnology Engineering, both from Tufts University.